PRAXIS HOME RETAIL LTD.
NSE : PRAXISBSE : 540901ISIN
CODE : INE546Y01022Industry : RetailingHouse
: Future
BSE17.90-0.35 (-1.92 % )
PREV CLOSE (Rs.) 18.25
OPEN PRICE (Rs.) 18.25
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 2351
TODAY'S LOW / HIGH (Rs.)
52 WK LOW / HIGH (Rs.)
NSE17.65 -0.35 (-1.94 % )
PREV CLOSE(Rs.) 18.00
OPEN PRICE (Rs.) 17.65
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 17.65 (92002 )
VOLUME 19259
TODAY'S LOW / HIGH(Rs.)
52 WK LOW / HIGH (Rs.)
Board Meetings
| Source Date | Board Meeting Date | Details |
|---|---|---|
| 26-Mar-2024 | 29-Mar-2024 | Inter-alia to consider and evaluate proposals for raising of funds by the Company in one or more tranches through one or more permissible mechanisms as may be deemed appropriate by the Board, by way of issuance of equity shares and/or other securities including share warrants convertible into Equity Shares of the Company and/or any other equity based instruments / securities through private placement or on rights or preferential issue basis or through any other permissible mode or any combination thereof and other matters related/ incidental thereto, as may be decided by the Board of Directors of the Company including the approval of the shareholders of the Company, wherever required. |
| 29-Jan-2024 | 06-Feb-2024 | Quarterly Results |
| 25-Oct-2023 | 03-Nov-2023 | Quarterly Results |
| 31-Jul-2023 | 07-Aug-2023 | Quarterly Results |
| 20-Jun-2023 | 22-Jun-2023 | Inter-alia to consider and evaluate proposals for raising of funds by the Company in one or more tranches through one or more permissible mechanisms as may be deemed appropriate by the Board, by way of issuance of equity shares and/or other securities including share warrants convertible into Equity Shares of the Company and/or any other equity based instruments/securities through private placement or on rights or preferential issue basis or through any other permissible mode or any combination thereof and other matters related/incidental thereto and subject to such statutory/regulatory approvals as may be necessary, including the approval of the shareholders of the Company, wherever required. |
| 19-May-2023 | 27-May-2023 | Audited Results |
| 19-May-2023 | 24-May-2023 | Right Issue of Equity Shares |
| 09-Mar-2023 | 14-Mar-2023 | Inter alia, to consider and evaluate proposals to raise funds by way of issuance of bonds including debentures / non-convertible debt instruments / securities and/or any other instruments / securities through private placement or on rights or preferential issue basis or through any other permissible mode or any combination thereof and other matters related/ incidental thereto. |
| 30-Jan-2023 | 06-Feb-2023 | Quarterly Results |
| 17-Oct-2022 | 03-Nov-2022 | Quarterly Results (Revised) |
